A testosterone replacement therapy (TRT) evaluation usually includes a full hormone panel and a broader look at overall health, but one of the values that keeps getting rechecked long after treatment starts is a plain, unglamorous one: hematocrit, the percentage of blood made up of red blood cells. It has nothing to do with libido, mood, or muscle, the things most people associate with testosterone. But it's one of the more consistently monitored labs in TRT care, and understanding why can make the monitoring feel less like fine print and more like a normal, expected part of treatment.
This is patient education, not medical advice. Only an independent licensed medical professional can determine whether testosterone therapy, and what monitoring around it, is appropriate for you.
Why testosterone therapy can raise red blood cell counts
Testosterone influences more than reproductive and muscle-related tissue; it also acts on the bone marrow, where red blood cells are made. In some people, testosterone therapy stimulates the marrow to produce red blood cells faster or in greater numbers than it otherwise would, a process sometimes called erythrocytosis. Because hematocrit measures the share of blood volume taken up by red blood cells, an increase in red blood cell production tends to show up directly as a rise in hematocrit on a lab report.
This effect is well recognized in testosterone product labeling, which is one reason hematocrit is treated as a standard, expected part of TRT monitoring rather than an occasional or optional check. It isn't limited to one form of testosterone either; it has been described across injectable, topical, and other formulations, though how much hematocrit rises can vary quite a bit from person to person. You can read more about how different delivery methods compare in our explainer on injectable, topical, and oral testosterone.
What hematocrit measures, and why it's checked before and during TRT
Hematocrit is a routine blood test reported as a percentage, part of a complete blood count (CBC) that most people have had done at some point, often without thinking much about it, during a general physical or a blood donation screening. It's usually reported alongside hemoglobin, another red-blood-cell measure, and both move in the same general direction.
In the context of TRT, hematocrit matters because blood that's unusually thick with red blood cells doesn't flow through smaller vessels as easily, which is why a meaningfully elevated hematocrit is something clinicians want to catch early rather than notice only after it becomes a bigger issue. A baseline hematocrit is typically checked before testosterone therapy starts, both to confirm it's in a safe range to begin treatment and to give your clinician a comparison point for later readings. From there, periodic rechecks, usually a few months into treatment and then at intervals your clinician sets based on your results, are a standard part of how TRT is prescribed and monitored more broadly, alongside testosterone levels and other labs.
| Stage | What typically happens | Why it's done |
|---|---|---|
| Before starting TRT | Baseline hematocrit is checked alongside other labs | Confirms it's safe to begin and sets a comparison point for later readings |
| Early in treatment | Hematocrit is usually rechecked a few months in | Testosterone's effect on red blood cell production is often noticeable relatively early |
| Ongoing treatment | Periodic rechecks continue at intervals your clinician sets | Hematocrit can keep shifting as dose, formulation, or health status changes |
| If hematocrit rises notably | Your clinician reassesses dose, frequency, or formulation | The goal is to bring levels back toward a safer range without abandoning treatment unnecessarily |
Signs and symptoms that may signal elevated hematocrit
Many people with a modestly elevated hematocrit feel completely normal and have no symptoms at all, which is exactly why routine lab monitoring, not just watching for symptoms, is the standard approach during TRT. When symptoms do show up, they can include headache, dizziness, a flushed or ruddy complexion, or, less commonly, visual disturbances. None of these are specific to hematocrit on their own; they have plenty of other possible causes, which is part of why a lab value, rather than a feeling, is what actually confirms what's going on.
Why elevated hematocrit is taken seriously even without symptoms
Thicker blood can affect circulation before it ever produces a symptom you'd notice. That's the whole point of checking hematocrit on a schedule rather than waiting for a warning sign, since by the time symptoms appear, if they appear at all, hematocrit may already be well above where your clinician wants it.
Who tends to be at greater risk
Not everyone on TRT sees the same rise in hematocrit, and clinicians pay closer attention in certain situations. People who start with a higher baseline hematocrit, older adults, and people using higher doses or certain injectable formulations tend to be discussed more often in connection with a larger rise. Underlying conditions that already affect red blood cell production or oxygen levels, including untreated or poorly controlled obstructive sleep apnea, smoking, and living at high altitude, are also relevant, since they can compound testosterone's effect on hematocrit rather than acting independently of it.
None of these factors automatically rule someone out from TRT. They're part of why a thorough health history matters as much as a testosterone level when a clinician decides how to start treatment and how closely to monitor it. If you're weighing whether TRT makes sense for you generally, our overview of what testosterone replacement therapy is covers how that broader evaluation works.
How elevated hematocrit is typically managed
When hematocrit rises more than a clinician wants to see, the response is rarely all-or-nothing. Depending on how high it's climbed and the broader picture, a clinician might lower the dose, spread injections out more evenly to smooth out peaks, switch to a different formulation, or, if levels are notably elevated, pause treatment temporarily until hematocrit comes back down. In some cases, they'll also look for and address a contributing factor, such as undiagnosed sleep apnea, rather than treating the hematocrit number in isolation.
Therapeutic phlebotomy, essentially donating or removing a measured amount of blood, is sometimes used for more pronounced elevations, though this is a decision made and directed by your clinician based on your specific labs, not something to pursue on your own. The overall goal across these options is the same: bring hematocrit back toward a safer range while keeping the parts of treatment that are working for you, rather than abandoning TRT altogether unless that turns out to be necessary.
Talking to your clinician about monitoring
Because hematocrit can rise without any noticeable symptoms, staying on schedule with your bloodwork matters more than trying to gauge how you feel. It's also worth being upfront about anything that could compound the effect, including snoring, witnessed pauses in breathing during sleep, smoking, or a family or personal history of blood disorders, since these details help your clinician interpret your results and decide how closely to watch you.
If you do notice new headaches, dizziness, or other symptoms between scheduled labs, it's reasonable to mention them to your clinician rather than waiting for your next appointment. Starting an online evaluation is a starting point for this kind of conversation, not a guarantee that TRT, or any specific monitoring schedule, will be prescribed; an independent licensed clinician reviews your health history and decides what's appropriate for you. You can explore more of our clinician-reviewed testosterone therapy explainers for related safety topics, including testosterone therapy and cardiovascular risk.
The bottom line
Testosterone therapy can increase red blood cell production in some people, raising hematocrit in a way that's well recognized in product labeling and closely tied to how TRT is monitored. Because elevated hematocrit doesn't always cause noticeable symptoms, routine lab checks before and throughout treatment, not just watching for warning signs, are the standard way this is managed. A rise in hematocrit doesn't automatically mean stopping treatment; it usually means a conversation with your clinician about adjusting the dose, formulation, or monitoring schedule to keep things in a safer range.
Important Safety Information
Indication. Testosterone replacement therapy is FDA-approved to treat adult men with low testosterone caused by specific medical conditions that affect the testicles, pituitary gland, or brain and reduce the body's natural testosterone production; it is not FDA-approved simply for a decline in testosterone associated with aging alone.
Common side effects. Acne or oily skin, injection-site or application-site reactions, fluid retention, increased red blood cell count (elevated hematocrit), and breast tenderness or enlargement have been reported.
Warnings. Testosterone product labeling describes a possible increased risk of heart attack and stroke and states that testosterone therapy may worsen obstructive sleep apnea in some people. Testosterone can increase red blood cell counts, requiring hematocrit monitoring before and periodically during treatment. Testosterone should not be used in men with breast cancer or known or suspected prostate cancer, and it may worsen symptoms of benign prostatic hyperplasia. Topical testosterone products carry warnings about the potential for secondary exposure to testosterone in children and women through skin contact.
Talk to your doctor. This information is educational and is not a substitute for medical advice. Only a licensed medical professional can determine whether a treatment is right for you. Talk to your doctor about the benefits and risks, and report any side effects.
Frequently asked questions
What is erythrocytosis, and why does testosterone therapy cause it?
Erythrocytosis is an increase in red blood cell production. Testosterone acts on the bone marrow, and in some people it stimulates the marrow to make red blood cells faster or in greater numbers than usual, which raises hematocrit, the percentage of blood made up of red blood cells. It's a recognized effect across different testosterone formulations and one reason hematocrit is checked regularly during treatment.
How is hematocrit monitored during TRT?
A baseline hematocrit is typically checked before testosterone therapy starts, then rechecked a few months into treatment, and periodically after that as part of routine follow-up. The exact schedule is individualized by your prescribing clinician based on your levels, your formulation, and how you're responding to treatment.
What symptoms might elevated hematocrit cause?
Many people with a modestly elevated hematocrit have no symptoms at all, which is why routine lab testing, not symptom-watching alone, is the standard approach. When symptoms do occur, they can include headache, dizziness, a flushed or ruddy complexion, or visual changes, though these have many possible causes and aren't specific to hematocrit alone.
What happens if my hematocrit gets too high on TRT?
Your clinician may adjust your dose, change your injection frequency or formulation, or temporarily pause treatment until levels come back down to a safer range. In some cases they may also evaluate you for other contributing factors, such as untreated sleep apnea. The specific approach is individualized and directed by a licensed clinician.
Does elevated hematocrit mean I have to stop TRT permanently?
Not necessarily. For many people, elevated hematocrit is managed with a dose or formulation change rather than stopping treatment altogether, and levels often come back down once adjustments are made. Whether a pause is temporary or treatment needs to stop for good depends on your individual situation and is a decision made with your clinician.
